-
Mashup Score: 1VibeRide | World's First Longboard Brake - 5 month(s) ago
Welcome to VibeRide, home of the longboard brake. We’re group of guys from Salt Lake City who’s love of downhill skating sparked the idea for what we hope to be the next big revolution.
Source: viberide.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0VibeRide | World's First Longboard Brake - 5 month(s) ago
Welcome to VibeRide, home of the longboard brake. We’re group of guys from Salt Lake City who’s love of downhill skating sparked the idea for what we hope to be the next big revolution.
Source: viberide.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial - 9 month(s) ago
It is unclear whether the effect of canagliflozin on adverse kidney and cardiovascular events in those with diabetic kidney disease varies by age and sex. We assessed the effects of canagliflozin among age group categories and between sexes in the Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study.
Source: www.ajkd.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0We Created the World's First Longboard Brake - 10 month(s) ago
Once you try it, you’ll never go back. VibeRide.com BrakeBoard: VibeRide.com/products/drop-through-brakeboardOver the past 4 years, we set out to create the …
Source: YouTubeCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Introducing the World's First Longboard Brake - 10 month(s) ago
Once you try it, you’ll never go back. VibeRide.com BrakeBoard: VibeRide.com/products/drop-through-brakeboardOver the past 4 years, we set out to create the …
Source: YouTubeCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Ozempic 3.0? Lilly’s ‘triple-G’ drug shows biggest weight loss yet in mid-stage trial - 10 month(s) ago
The battle to provide obesity treatments jumps to a new level, with Eli Lilly announcing that an experimental drug that acts on three hormones (rather than the single target in Novo Nordisk’s Wegovy) led to substantial weight loss.
Source: STATCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2HCM | Cardiometabolic CE - 12 month(s) ago
Surgical Considerations in Management of HCM May 17, 2023 | HCM1b) Our distinguished faculty is Hartzell Schaff, MD, @HSchaffMD, Cardiovascular Surgeon @MayoClinic, and President, American Association for Thoracic Surgery @AATSHQ. Also contributing is Fernando Juarez-Casso @FernandoM_JC.#FOAMed #cardiotwitter @MedTweetorials #HCM… HCM: The…
Source: cardiometabolic-ce.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1FDA Extends Dapagliflozin Indication Across LVEF Spectrum - 12 month(s) ago
The expanded approval is based on the positive results from DELIVER and mirrors last year’s decision for empagliflozin.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Patients and Physician Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation - 1 year(s) ago
This cohort study assesses the perceptions of patients with atrial fibrillation and their physicians about the benefits and risks of anticoagulation.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2👯 Who is your Twitter twin? - 1 year(s) ago
Discover your twin on Twitter now!
Source: ToasteedCategories: Cardiologists, Latest HeadlinesTweet
RT @rideviberide: The race is on... https://t.co/Fn4XvgZdm2 https://t.co/H7YlrRf08G